YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Drug Interaction between Nimodipine and Cyclosporine in Rabbits

가토에서 니모디핀과 싸이크로스포린과의 약물상호작용

  • Published : 2002.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to report the pharmacokinetic changes of cyclosporine after oral administration of cyclosporine, 10 mg/kg, in rabbits coadministered or pretreated twice per day for 3 days with nimodipine, dose of 5 mg/kg. The area under the plasma concentration-time curve (AUC) of cyclosporine was significantly higher in rabbits pretreated with nimodipine than that in control rabbits (p＜0.01), showing about 149％ increased relative bioavailability. The peak plasma concentration (C$_{max}$), elimination half-life (t$_{1}$2/) and MRT of cyclosporine were increased significantly (p＜0.05) in rabbits pretreated with nimodipine compared with those in control rabbits. This findings could be due to significant reduction of elimination rate constant and total body clearance by pretreated with nimodipine. The effects of nimodipine on the pharmacokinetics of oral cyclosporine were more considerable in rabbits pretreated with nimodipine compared with those in control rabbits. The results suggest that the dosage of cyclosporine should be adjusted when the drug would be coadministered chronically with nimodipine in a clinical situation.n.

Keywords

References

  1. AHFS. AFS 2570, 2576 (1995)
  2. Borel, J. F. : The history of cyclosporine A and its significance. Elsvier 5, 121 (1982)
  3. Keown, P. A. : Immunological and pharmacological monitoring in clinical use of cyclosporine A. Lancet 1, 686 (1981)
  4. Morse, G. D.: Pharmacokinetics and clinical tolerance of intraveneous and oral cyclosporine in the immediate postoperative period. Clin Pharmacol Ther. 44, 654 (1988)
  5. Gupta, S. K. : Pharmacokinetics of cyclosporine influence of rate of constant intraveneou infusion in renal transplant patients. Brit J Clin Pharmacol. 24, 519 (1987)
  6. Ried, M. : Cyclosporine levels in human tissues of patients treated for one week to one year. Transplant Proc. 15, 2424 (1983)
  7. Rodighiero, V. : Therapeutic drug monitoring of cyclosporine : practical application and limitation. Clin Pharmacokinetic 16, 27 (1989) https://doi.org/10.2165/00003088-198916010-00002
  8. Gupta, S. K. : Effects of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intraveneous administration. J Clin Pharmacol. 30, 643 (1990)
  9. Guengerich, P. F. : Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for generic polymorpism in oxidative drug metabolism. J Biol Chem. 261, 5051 (1986)
  10. Watkins, P. B. : Erythromycin breath test as an assay of inducers and inhibitors od cytochrome P-450 : studies in rats and patients. J Clin Invest, 83, 688 (1989)
  11. Mauer, G. : Disposition of cyclosporine in several animal species and man: stuructural elucidation of its metabolites. Drug Metab Dispos. 12, 120 (1984)
  12. Lensmeyer, G. L. : Identification and analysis of metabolites of cyclosporine in whole blood by liquid chromatography. Clin Chem, 3, 1851 (1987)
  13. Wenger, R. M. : Structure of cyclosporine and its metabolites. Transplant Proc. 22, 1804 (1990)
  14. Christians, U. : Measurement of cyclosporineand 18 metabolites in blood, bile and urine by high performance liquid chromatography. Transplant Proc. 20, 609 (1988)
  15. Yee, G. C. : Measurement of blood cyclosporine metabolites concentrations with new column switching high performance liquid chromatographic assay. Transplant Proc, 20, 585 (1988)
  16. Rosano,T.G. : Immunosuppressive metabolites ofcyclosporine in the blood renal allograft recipents. Transplantation 42, 262 (1986)
  17. Ryffel, B., Hiesstand, P. and Foxwell, B. : Nephrotoxic and immunosuppressive potentials of cyclosporine metabolites in rats. Transplant Proc. 18, 6 (1986)
  18. Pichard, L., Cyclosporine, A. drug interaction : screening for inducers and inhibitors of cytochrome P-450 in primary cultures of human hepatocytes and liver microsomes. Drug Metab. 18, 595 (1990)
  19. Keown, P. A., Stiller, C. R. and Laupacis, A. L. : The effects and side effects of cyclosporine relationship to drug pharmacokinetic interaction with phenytoin. Transplant Proc, 14, 659 (1982)
  20. Keown, P. A. : Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation 38, 304 (1984)
  21. Lele, P., Penterson, P. and Burke, J. E. : Cyclosporin and tegretol interaction. Kidney Int. 27, 344 (1985)
  22. Daniels, N. J. : Interaction between cyclosporine and rifampicin. Lancet, 2, 639 (1984)
  23. Jarowenko M. V. and Lober M. I. : Ranitidine, cimetidine and the cyclosporine treated recipients. Transplantation 42, 311 (1986)
  24. Puff, M. R. : Cimetidine alters cyclosporine A metabolism in liver transplant ients. Gastroenterol. 96, 647 (1989)
  25. Zylber-Katz, E., Rubinger, D. and Berlatsky. Y. : Cyclosporine interactions with metronidazole and cimetidine. Drug Intell Clin pharm, 22, 504 (1988)
  26. Tan, KKC., Trull, A. K. and Shawket, S. : Study of the potential pharmacokinetic interaction beteen ciprofloxacin and cyclosporine in man. Br J Clin Phamacol. p, 644, 26 (1988)
  27. Elston, R. A and Taylor, J. : Possible interaction of ciprofloxacin with cyclosporine A. J Antimicrob Chemother, 29, 679 (1988)
  28. Thomson, D. J., Menkis, A H. and Mckenzie, F. N. : Norfioxacin-ciprofloxacin interaction. Transplantation 46, 312 (1988)
  29. Hourmant, M., Le Bigot, J. E, Vernillet, L., Sagniez, G., Remi, J. P. and Soulilou, J. P. : Coadministration of erythromycin results in an increase of blood cyclosporine to toxic levels. Transplant Proc. 17, 2723 (1985)
  30. Murray, B. M., Edwards, L., Morse, G. D., Kohli, R. R. and Venuto, R. C. : Clinically important interaction of cyclosporine and erythromycin. Transplantation 43, 602 (1987)
  31. Shepard, J.H., Canafax, D. M., Simmons, R. L. and Najarian, J. S. Cyclosporine-Ketoconazole, : a potentially dangerous drugdrug interaction. Clin. Pharm, 5, 468 (1986)
  32. Gumbleton, J. H., Brown, J. E., Hawksworth, G. and Whiting, P. H. : The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity. Transplantation 40, 454 (1985)
  33. Trenk, D., Brett, W, Jahnchen, E. and Birnbaum, D. : Time course of cyclosporine/itraconazole interaction. CLancet, ii. 1335 (1987)
  34. Kruger, H. U., Schuler, D., Zimmerman, R. and Ehninger, G. : Absence of significant interaction of fluconazole with cyclosporine. J Antimicrob Chemother. 24, 781 (1989) https://doi.org/10.1093/jac/24.5.781
  35. Grino, J. M., Sabate, I., Castelao, A. M. and Alsina. : Influence of diltiazem on cyclosporin clearance. Lancet, I. 1387 (1986)
  36. Madsen, J. K., et. al, Drug interaction between cyclosporine and felodipine. 52, 161 (1997)
  37. Wagner, K., Albrecht, S. and Neumayer H-H. : Prevention of delayed graft function by a calcium antagonist-a randomized trial in renal graft recipients on cyclosporin A. Transplant Proc. 18, 1269 (1986)
  38. Brockmoller, R. A., Wagner, K.,Neumayer, H-H. and Heinemeyer, G. : Interaction of cyclosporine and diltiazem. Naunyn-Schmied Arch Pharmakol, suppl R 126, 337 (1988)
  39. Wagner, K., Philipp, Th., Heinemeyer, G., Brockmuller, F, Roots, I. and Neumayer, H-H. : Interaction of ciclosporin and calcium antagonists. Transplant Proc. 1453, 6 (1989)
  40. Cantarovich, M., Hiesse, C., Lockiet, F., Charpentier, B. and Fries, D. : confirmation of the interaction cyclosporin and calcium channel blocker nicardipine in renal transplant patients. Clin Nephrol. 28, 190 (1987)
  41. Deray, G., Aupeptit, B., Martinez, E, Baumelou, A, Worcel, A., Benhmikda, M., Lagrand, J. C. and Jacobs, C. : cyclosporinnicardipine interaction. Am J Nephrol. 9, 349 (1989) https://doi.org/10.1159/000167993
  42. Kessler, M., Netter, P., Renoult, E., Jonon, B., Mur, J. M., Trechot, P. and Dousset, B. : Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients. Eur J Clin Pharmacol. 36, 637 (1989) https://doi.org/10.1007/BF00637751
  43. Mcfadden, J. P., Pontin, J. E., Powles, A V., Fry; L. and Idle, J. R. : cyclosporin desrease nifedipine metabolism. Br Med J. 299, 1224 (1989)
  44. Mcnally, P., Mistry, N., Idle, J., Walls, J. and Freehally, J. : Calcium channel blockers and cyclosporin metabolism. Transplantation, 48, 1071 (1989) https://doi.org/10.1097/00007890-198912000-00038
  45. Robson, R. A., Fraenkel, M., Barratt, L. J. and Birkett, D. J. : cyclosporin Verapamil interaction. Br J Clin Pharmac. 25, 405 (1988)
  46. Angermann, C. E., Spes, C. H., Anthuber, M., Kemkes, B. M. and Theisen, K. : Verapamil incrases cyclosporine-A blood troughlevels in cardiac recipients. J Amer Coli Cardiol. 11, 206A (1988)
  47. Dawidson, I., Rooth, P., Fry; W. R., Sandor, Z., Willms, C., Coorpender, L., Alway; C. and Reisch, J. : Prevention of acute cyclosporin induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation 484, 575 (1989)
  48. Sabate, I., Grino, J. M., Castelao, A. M. and Ortloa, J. : Evaluation of cyclosporin-verapamilinteraction, with observations on parent cyclosporin and metabolites. Clin Chem. 34, 2151 (1989)
  49. Choi, J. S., Choi, B. C. and Burm, J. P. : Pharmacokinetics of cyclosporine in rabbits with carbon tetrachloride and bil duct ligation-induced hepatic disorder. J Pharm Soc Korea 42, 181 (1998)
  50. Agarwal, R. P. : Assessment of cyclosporine a in the whole blood and plasma in patients with different hematochrits. Ther Drug Monit. 16, 331 (1985)
  51. Rocci, M. L. and Jusko, W. J. : LAGRAN program for area and moments in pharmacokinetic analysis. Computer Program in Biomedicine 16, 203 (1983)